Read-only access that allows for near real-time monitoring of clinical data at small clinical biotech company
February 15, 2020

Read-only access that allows for near real-time monitoring of clinical data at small clinical biotech company

Anonymous | TrustRadius Reviewer
Score 6 out of 10
Vetted Review
Verified User

Overall Satisfaction with IBM Clinical Development

Zelta by Merative is being used by our external CRO and our internal Clinical department to track patient data and progress on 3 of our ongoing company-sponsored clinical trials. However, I have access to monitor the progress of the trials and patient status. Management must understand the near real-time progress of our clinical trials so we can make informed decisions and data analyses as possible.

Pros

  • Tracking data entry
  • Allowing for data queries for accuracy & completeness

Cons

  • More user friendly and useful data reports
  • Live graphing of trial data
  • Allowed us to analyze accuracy of data entry at clinical sites
  • Tracking patient recruitment to identify high efficiency sites
I am not involved in the direct support and maintenance of the database. However, my colleagues have always been able to establish my appropriate access.

Do you think Zelta delivers good value for the price?

Yes

Are you happy with Zelta's feature set?

Yes

Did Zelta live up to sales and marketing promises?

I wasn't involved with the selection/purchase process

Did implementation of Zelta go as expected?

No

Would you buy Zelta again?

Yes

Smaller company clinical trial tracking using an external CRO. Zelta is critical. You design the database correctly upfront and have an experienced and detailed data management professional who understands the clinical data and analyses desired.

Comments

More Reviews of Zelta